Cargando…
Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy
BACKGROUND: Understanding the role of alternative complement pathway dysregulation in membranoproliferative glomerulonephritis (MPGN) has led to a dramatic shift in its classification into two subgroups: immune complex-mediated MPGN and complement-mediated MPGN, consisting of dense deposit disease a...
Autores principales: | Kersnik Levart, Tanja, Ferluga, Dušan, Vizjak, Alenka, Mraz, Jerica, Kojc, Nika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055692/ https://www.ncbi.nlm.nih.gov/pubmed/27717365 http://dx.doi.org/10.1186/s13000-016-0547-6 |
Ejemplares similares
-
IgA-dominant acute poststreptococcal glomerulonephritis with concomitant rheumatic fever successfully treated with steroids: a case report
por: Rus, Rina R, et al.
Publicado: (2015) -
Post-vaccine glomerulonephritis in an infant with hereditary C2 complement deficiency: case study
por: Kersnik Levart, Tanja
Publicado: (2013) -
Urinary Immunoglobulin G to Albumin Ratio and N-Acetyl-Beta-D-Glucosaminidase as Early Predictors of Therapeutic Response in ANCA-Associated Glomerulonephritis
por: Mravljak, Marija, et al.
Publicado: (2013) -
Clinical outcome is associated with the Urinary Tract Dilatation Classification System grade
por: Bratina, Petra, et al.
Publicado: (2020) -
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
por: Chanchlani, Rahul, et al.
Publicado: (2017)